Novel Strategies for Treating Castration-Resistant Prostate Cancer

The development of castration resistance is an inevitable pathway for the vast majority of patients with advanced prostate cancer. Recently, there have been significant breakthroughs in the understanding and management options of castration-resistant prostate cancer. Three novel hormonal agents show...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, David Ka-Wai, Chiu, Peter Ka-Fung, Ng, Chi-Fai, Teoh, Jeremy Yuen-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066514/
https://www.ncbi.nlm.nih.gov/pubmed/33801751
http://dx.doi.org/10.3390/biomedicines9040339
_version_ 1783682587017871360
author Leung, David Ka-Wai
Chiu, Peter Ka-Fung
Ng, Chi-Fai
Teoh, Jeremy Yuen-Chun
author_facet Leung, David Ka-Wai
Chiu, Peter Ka-Fung
Ng, Chi-Fai
Teoh, Jeremy Yuen-Chun
author_sort Leung, David Ka-Wai
collection PubMed
description The development of castration resistance is an inevitable pathway for the vast majority of patients with advanced prostate cancer. Recently, there have been significant breakthroughs in the understanding and management options of castration-resistant prostate cancer. Three novel hormonal agents showed survival benefits in non-metastatic patients. As for metastatic disease, there was an even wider range of management options being investigated. This review summarized advances in the management of castration-resistant prostate cancer (CRPC) including emerging data on novel imaging techniques and treatment strategies.
format Online
Article
Text
id pubmed-8066514
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80665142021-04-25 Novel Strategies for Treating Castration-Resistant Prostate Cancer Leung, David Ka-Wai Chiu, Peter Ka-Fung Ng, Chi-Fai Teoh, Jeremy Yuen-Chun Biomedicines Review The development of castration resistance is an inevitable pathway for the vast majority of patients with advanced prostate cancer. Recently, there have been significant breakthroughs in the understanding and management options of castration-resistant prostate cancer. Three novel hormonal agents showed survival benefits in non-metastatic patients. As for metastatic disease, there was an even wider range of management options being investigated. This review summarized advances in the management of castration-resistant prostate cancer (CRPC) including emerging data on novel imaging techniques and treatment strategies. MDPI 2021-03-27 /pmc/articles/PMC8066514/ /pubmed/33801751 http://dx.doi.org/10.3390/biomedicines9040339 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Review
Leung, David Ka-Wai
Chiu, Peter Ka-Fung
Ng, Chi-Fai
Teoh, Jeremy Yuen-Chun
Novel Strategies for Treating Castration-Resistant Prostate Cancer
title Novel Strategies for Treating Castration-Resistant Prostate Cancer
title_full Novel Strategies for Treating Castration-Resistant Prostate Cancer
title_fullStr Novel Strategies for Treating Castration-Resistant Prostate Cancer
title_full_unstemmed Novel Strategies for Treating Castration-Resistant Prostate Cancer
title_short Novel Strategies for Treating Castration-Resistant Prostate Cancer
title_sort novel strategies for treating castration-resistant prostate cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066514/
https://www.ncbi.nlm.nih.gov/pubmed/33801751
http://dx.doi.org/10.3390/biomedicines9040339
work_keys_str_mv AT leungdavidkawai novelstrategiesfortreatingcastrationresistantprostatecancer
AT chiupeterkafung novelstrategiesfortreatingcastrationresistantprostatecancer
AT ngchifai novelstrategiesfortreatingcastrationresistantprostatecancer
AT teohjeremyyuenchun novelstrategiesfortreatingcastrationresistantprostatecancer

Ejemplares similares